| Financial Year |
March 31 2023 |
| Monetary Funds |
243,059,053.02 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
153,906,646.77 |
| Advances to Suppliers |
15,462,939.65 |
| Other Receivables |
5,815,119.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,506,770,347.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,765.69 |
| Total Current Assets |
1,925,026,872.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
44,854,102.36 |
| Investment Properties |
4,288,269.74 |
| Fixed Assetes |
30,881,624.60 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
8,615,376.76 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,293,401.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
127,972.86 |
| Deferred Income Tax Assets |
912,784.66 |
| Other Non-Current Assets |
4,193,145.47 |
| Sub-Total of Non-Current Assets |
138,250,130.56 |
| Total Assets |
2,063,277,002.90 |
| Short-Term Loans |
240,683,023.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
26,822,210.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,285,733.71 |
| Taxes Payable |
1,302,581.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,032,377.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
64,766,229.07 |
| Other Current Liabilities |
68,637.83 |
| Sub-Total of Current Liabilities |
358,635,606.57 |
| Long-term Loans |
952,161,938.27 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
958,587,557.21 |
| Total Liabilities |
1,317,223,163.78 |
| Paid-In Capital(Or Share Stock) |
235,756,000.00 |
| Capital Surplus |
244,549,936.00 |
| Surplus Reserve |
30,699,814.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
234,741,535.01 |
| Minority Stockholder's Interest |
306,553.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
745,747,285.42 |
| Owner's Equity（Stockholder's Equity） |
746,053,839.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,063,277,002.90 |
